Dexamethasone metasulfobenzoate

DB14703ApprovedSmall molecule

Dexamethasone metasulfobenzoate is an ophthalmic and auricular corticosteroid used with antibiotics for the treatment of otitis externa, blepharitis, and other inflammatory eye conditions. A medication combined with antibiotics to help treat ear infections, eye infections, and other eye conditions.

Formula / weight: C₂₉H₃₃FO₉S · 576.63 g/mol (avg)
First approval: Canada, 2005
Also known as: Dexamethasone m-sulfobenzoate
Brand names: Sofracort

Resolves to

Compound

UNIIC67221CB9QCAS16978-57-7ChEMBLCHEMBL3305965

Structure

InChIKeyTWQWRHIQRAZHPR-XNXCGYEVSA-NSMILES

[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C3=CC=CC(=C3)S(O)(=O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C

What you can answer from here — as of September 13, 2026

1Clinical trialPhase, status and sponsor resolved per trial

6Marketed productsAcross 3 countries and 6 labellers

Which companies are running trials of Dexamethasone metasulfobenzoate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account